Drug Profile
BMY 42393
Alternative Names: BMY 45491; BMY 45778Latest Information Update: 26 Jul 1994
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Antihyperlipidaemics; Antiplatelets
- Mechanism of Action Epoprostenol agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia